A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of TAB008 and bevacizumab in healthy volunteers.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e14504
Abstract: e14504Background: This study compared the pharmacokinetic (PK) profiles of the biosimilar TAB008 with bevacizumab (EU) in healthy adult males. Methods: A randomized, double-blind, single-dose study... read more here.
Keywords: bevacizumab healthy; study; tab008 bevacizumab; single dose ... See more keywords